IQVIA Hldgs (NYSE:IQV) Stock, Quote.Headers.trade-ideas

IQVIA HOLDINGS INC

IQVIA Hldgs

Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

IQVIA Holdings

Konskie,,Poland,-,January,03,,2024:,Nvidia,Company,Logo,Displayed

Large Cap

News

Health Care

Tech

General

NVDA

Nvidia teams up with Novo Nordisk and IQVIA to boost AI-powered drug development and streamline complex pharmaceutical workflows.

Nvidia Just Partnered With A Weight-Loss Giant, But It&#39;s Not About Pills

IQV Stock Cakra Adhishthana

Equities

Technicals

Opinion

Signals

Trading Ideas

IQVIA stock may look ready for a breakout, but Adhishthana analysis reveals a complex time spiral that could last until 2030.

IQVIA Stock: Stuck In A Time Spiral - Value Play Or Bull Trap?

wall street ai9

Analyst Color

Economics

Analyst Ratings

BIIB

ENPH

REGN

TECH

Only about 50% of S&amp;P 500 stocks trade above their 200-day average, signaling narrow breadth even as the index rallies 22% since April.

Only Half Of S&amp;P 500 Stocks Joined The Tariff-Relief Rally: Time To Buy The Laggards?

IQVIA Holdings Inc

Press Releases

IQVIA named a front-runner in generative AI innovation by global industry research and analysis firm

IQVIA celebrates Marie E. Lamont and Dr. Joanne Hackett, winners of Healthcare Businesswomen's Association Awards

IQVIA Reports First-Quarter 2025 Results

IQVIA CFO Ron Bruehlman to speak at the Bank of America Annual Health Care Conference on May 13

IQVIA and SCRI Collaborate to Accelerate Global Oncology Trials

Rein Therapeutics Announces First Patient Dosed in RENEW Phase 2 Trial of LTI-03 in Patients with IPF

IQVIA Announces Offering of Senior Notes

IQVIA Announces Pricing of Senior Notes

IQVIA Launches New AI Agents for Life Sciences and Healthcare

IQVIA Health Research Space Wins 2025 MedTech Breakthrough Award for 'Best Mobile App for Patient Engagement'

RNTX

Agilent Technologies

AbCellera Biologics

Adaptive Biotechnologies Corporation - Common Stock

Adaptive Biotechnologies

Avantor

Azenta

Bio-Rad Laboratories, Inc. Class A Common Stock

Bio-Rad Laboratories

BioLife Solutions

Bruker

Charles River Laboratories International, Inc. Common Stock

Charles River

Danaher

Evotec SE - American Depositary Shares each representing 1/2 of one ordinary share

Comments

IQVIA Hldgs

IQVIA Hldgs (NYSE:IQV) Stock, Quote.Headers.trade-ideas

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell